The Arab Drug Company (EGX:ADCI)
Egypt
· Delayed Price · Currency is EGP 149.95
+3.78 (2.59%)
At close: Mar 13, 2025
The Arab Drug Company Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 12, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 900 | 482 | 401 | 275 | 397 | 354 | Upgrade
|
| Market Cap Growth | 97.13% | 20.27% | 45.83% | -30.70% | 12.18% | 98.95% | Upgrade
|
| Enterprise Value | 1,306 | 766 | 505 | 302 | 355 | 305 | Upgrade
|
| Last Close Price | 149.95 | 74.61 | 57.80 | 36.04 | 47.45 | 39.57 | Upgrade
|
| PE Ratio | 7.31 | 5.46 | 5.64 | 3.60 | 3.91 | 3.81 | Upgrade
|
| Forward PE | - | 8.58 | 8.58 | 8.58 | 8.58 | 8.58 | Upgrade
|
| PS Ratio | 0.97 | 0.61 | 0.63 | 0.54 | 0.74 | 0.68 | Upgrade
|
| PB Ratio | 1.79 | 1.05 | 1.05 | 0.81 | 1.28 | 1.42 | Upgrade
|
| P/TBV Ratio | 1.64 | 1.05 | 1.05 | 0.81 | 1.28 | 1.42 | Upgrade
|
| P/FCF Ratio | 26.65 | - | 16.49 | - | 51.48 | 5.00 | Upgrade
|
| P/OCF Ratio | 6.63 | 3.55 | 4.58 | 8.37 | 10.85 | 4.83 | Upgrade
|
| EV/Sales Ratio | 1.41 | 0.97 | 0.80 | 0.60 | 0.66 | 0.59 | Upgrade
|
| EV/EBITDA Ratio | 6.74 | 5.98 | 5.08 | 3.01 | 2.73 | 2.59 | Upgrade
|
| EV/EBIT Ratio | 7.39 | 6.48 | 5.20 | 3.32 | 2.90 | 2.60 | Upgrade
|
| EV/FCF Ratio | 38.70 | - | 20.77 | - | 46.03 | 4.32 | Upgrade
|
| Debt / Equity Ratio | 1.01 | 1.13 | 0.50 | 0.44 | 0.07 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 2.62 | 4.01 | 1.91 | 1.51 | 0.16 | 0.12 | Upgrade
|
| Debt / FCF Ratio | 15.06 | - | 7.89 | - | 2.75 | 0.20 | Upgrade
|
| Asset Turnover | 0.82 | 0.87 | 1.01 | 0.99 | 1.31 | 1.55 | Upgrade
|
| Inventory Turnover | 2.25 | 2.12 | 1.71 | 1.61 | 1.85 | 2.08 | Upgrade
|
| Quick Ratio | 0.71 | 1.01 | 0.73 | 0.68 | 0.80 | 0.76 | Upgrade
|
| Current Ratio | 1.46 | 1.93 | 2.49 | 2.31 | 2.75 | 2.64 | Upgrade
|
| Return on Equity (ROE) | 31.34% | 24.43% | 22.88% | 23.48% | 36.32% | 42.35% | Upgrade
|
| Return on Assets (ROA) | 9.73% | 8.13% | 9.66% | 11.12% | 18.67% | 21.87% | Upgrade
|
| Return on Capital (ROIC) | 11.61% | 9.52% | 11.38% | 13.80% | 25.73% | 31.14% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.53% | 15.03% | 19.81% | 23.12% | 39.47% | 47.14% | Upgrade
|
| Earnings Yield | 13.67% | 21.32% | 20.64% | 27.74% | 25.55% | 26.23% | Upgrade
|
| FCF Yield | 3.75% | -17.24% | 6.07% | -20.74% | 1.94% | 19.98% | Upgrade
|
| Dividend Yield | 5.57% | 11.19% | 7.79% | 13.32% | 10.54% | 6.32% | Upgrade
|
| Payout Ratio | 36.77% | 35.11% | 45.29% | 57.06% | 38.31% | 34.69% | Upgrade
|
| Buyback Yield / Dilution | -7.67% | - | 11.45% | 2.11% | 6.76% | 6.65% | Upgrade
|
| Total Shareholder Return | -2.11% | 11.19% | 19.24% | 15.43% | 17.30% | 12.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.